Indefinite Delivery Contract SPE2DX15D9145

The federal contract IDV award SPE2DX15D9145 is a single-award Indefinite Delivery Contract (IDC) granted by the Defense Logistics Agency (DLA) to the prime contractor, DMS Pharmaceutical Group Inc., a woman-owned small business. The contract, valued at up to $4,999,999, covers the delivery of a comprehensive range of pharmaceutical products and medical supplies, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical needs of military healthcare facilities and veterans' medical centers nationwide. The IDC, which is part of the DLA's SPE2DX program, has an ultimate completion date of December 31, 2025, and enables the agency to issue firm fixed-price delivery orders for a diverse array of pharmaceutical items, such as injections, tablets, creams, auto-injectors, and specialty medications. As a key supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group leverages its status as a woman-owned small business to secure direct federal awards across multiple product categories and medical domains, further positioning the company as a crucial provider of prescription drugs and pharmacy services to the Department of Defense healthcare system.